These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27592472)

  • 1. Study on breast cancer animal model of tumor-micro vessel variation before and after the chemotherapy by contrast enhanced ultrasound quantitative analysis.
    Zhou SC; Le J; Fan YW; Chen M; Chang C
    Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1407-13. PubMed ID: 27592472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can quantitative contrast-enhanced ultrasonography predict cervical tumor response to neoadjuvant chemotherapy?
    Peng C; Liu LZ; Zheng W; Xie YJ; Xiong YH; Li AH; Pei XQ
    Eur J Radiol; 2016 Nov; 85(11):2111-2118. PubMed ID: 27776666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Evaluation of Combretastatin A4 Phosphate Early Efficacy in a Tumor Model with Dynamic Contrast-Enhanced Ultrasound.
    Zhang P; Chen Y; Liu J; Yang Y; Lv Q; Wang J; Zhang L; Xie M
    Ultrasound Med Biol; 2018 Apr; 44(4):840-852. PubMed ID: 29395676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationship in cisplatin-treated breast cancer xenografts monitored with dynamic contrast-enhanced ultrasound.
    Chen Y; Han F; Cao LH; Li C; Wang JW; Li Q; Zheng W; Guo ZX; Li AH; Zhou JH
    BMC Cancer; 2015 Mar; 15():136. PubMed ID: 25884471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Analysis of Hepatic Microcirculation in Rabbits After Liver Ischemia-Reperfusion Injury Using Contrast-Enhanced Ultrasound.
    Li H; Lu J; Zhou X; Pan D; Guo D; Ling H; Yang H; He Y; Chen G
    Ultrasound Med Biol; 2017 Oct; 43(10):2469-2476. PubMed ID: 28684184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative parameters of contrast-enhanced ultrasound in breast invasive ductal carcinoma: The correlation with pathological prognostic factors.
    Ji CL; Li XL; He YP; Li DD; Gu XG; Xu HX
    Clin Hemorheol Microcirc; 2017; 66(4):333-345. PubMed ID: 28387663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced US quantitatively detects changes of tumor perfusion in a murine breast cancer model during adriamycin chemotherapy.
    Wang JW; Cao LH; Han F; Zheng W; Chen Y; Li AH; Zhou JH
    Acta Radiol; 2013 Oct; 54(8):882-8. PubMed ID: 23761553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy.
    Mahéo K; Chevalier S; Vibet S; Bougnoux P; Richard S; Serrière S; Bleuzen A; Tranquart F; Goupille C
    Breast Cancer Res Treat; 2012 Aug; 134(3):1013-25. PubMed ID: 22438047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer.
    Cao X; Xue J; Zhao B
    Ultrasound Med Biol; 2012 Dec; 38(12):2065-71. PubMed ID: 23062366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.
    Saracco A; Szabó BK; Tánczos E; Bergh J; Hatschek T
    Acta Radiol; 2017 Apr; 58(4):394-402. PubMed ID: 27461224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy.
    Wan CF; Liu XS; Wang L; Zhang J; Lu JS; Li FH
    Eur J Radiol; 2018 Jun; 103():118-123. PubMed ID: 29803376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of early tumor response to cytotoxic chemotherapy with dynamic contrast-enhanced ultrasound in human breast cancer xenografts.
    Wang JW; Zheng W; Liu JB; Chen Y; Cao LH; Luo RZ; Li AH; Zhou JH
    PLoS One; 2013; 8(3):e58274. PubMed ID: 23469274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Response Assessed by Contrast-Enhanced Ultrasound in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
    Dong T
    Ultrasound Q; 2018 Jun; 34(2):84-87. PubMed ID: 29420367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Prediction of Response to Neoadjuvant Chemotherapy Using Quantitative Parameters on Automated Breast Ultrasound Combined with Contrast-Enhanced Ultrasound in Breast Cancer.
    Xie Y; Chen Y; Wang Q; Li B; Shang H; Jing H
    Ultrasound Med Biol; 2023 Jul; 49(7):1638-1646. PubMed ID: 37100671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
    Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ
    Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of treatment responses to neoadjuvant chemotherapy in breast cancer using contrast-enhanced ultrasound.
    Huang Y; Le J; Miao A; Zhi W; Wang F; Chen Y; Zhou S; Chang C
    Gland Surg; 2021 Apr; 10(4):1280-1290. PubMed ID: 33968680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.
    Pietras K; Hanahan D
    J Clin Oncol; 2005 Feb; 23(5):939-52. PubMed ID: 15557593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer.
    Fujisawa T; Hirakata T; Yanagita Y; Iijima M; Horikoshi H; Takeuchi K; Saitoh Y
    Breast Cancer; 2013 Jan; 20(1):75-82. PubMed ID: 22203579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.
    Merz M; Komljenovic D; Semmler W; Bäuerle T
    Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.